HBV Mutation Detail Information

> L180M Search Result


Mutation Information
Mutation Site L180M
Mutation Type Amino acid level
Gene/Protein/Region Type RT
Combined Mutation rt.M204I+rt.L180M
Viral Reference AY090460; AF160501; X75658; X75657; V01460; X01587; D00329; X02763
Relevant Drug lamivudine (LAM);telbivudine (LDT)
Country America
Literature Information
PubMed PMID 21723325
Disease HBV infection
Published Year 2011
Journal Journal of virological methods
Title Development and validation of a hepatitis B virus DNA sequencing assay for assessment of antiviral resistance, viral genotype and surface antigen mutation status.
Author Mallory MA,Page SR,Hillyard DR
Evidence Mutations conferring resistance to lamivudine and telbivudine were most common (rtL180M and rtM204I/V) (74.3% of total mutant samples).

Contents
Description
Mutation Information Note
  • Gene/Protein/Region Type: Virus Gene (e.g. LMP-1) or Virus Protein (e.g. Rep 68) or Virus Region (e.g. S, X)
Literature Information Note
  • Evidence: sentence contains this mutation information in the citation